BamSEC and AlphaSense Join Forces
Learn More

Inhibikase Therapeutics Inc. – Articles of Incorporation

NASDAQ: IKT    
Share price (4/6/26): $1.79    
Market cap (4/6/26): $236 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 31 pages Amended and Restated Bylaws of Inhibikase Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 8 pages Amended and Restated Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 8 pages Delaware Page 1 the First State
12/34/56
EX-3.4
from S-1 31 pages Amended and Restated Bylaws of Inhibikase Therapeutics, Inc
12/34/56
EX-3.3
from S-1 9 pages Bylaws of Inhibikase Therapeutics, Inc
12/34/56
EX-3.2
from S-1 9 pages Amended and Restated Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56
EX-3.1
from S-1 4 pages State of Delaware Certificate of Conversion From a Limited Liability Company to a Corporation Pursuant to Section 265 of the Delaware General Corporation Law
12/34/56
EX-3.4
from DRS/A 31 pages Amended and Restated Bylaws of Inhibikase Therapeutics, Inc
12/34/56
EX-3.3
from DRS/A 8 pages Bylaws of Inhibikase Therapeutics, Inc
12/34/56
EX-3.2
from DRS/A 8 pages Amended and Restated Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56
EX-3.1
from DRS/A 2 pages State of Delaware Secretary of State Division of Corporations Delivered 05:00 Pm 06/03/2010 Filed 05:00 Pm 06/03/2010 Srv 100626606 - 4832244 File Certificate of Incorporation of Inhibikase Therapeutics, Inc
12/34/56